Tirzepatid und Semaglutid sind beides injizierbare Medikamente, die zur Gewichtsabnahme und -abnahme verwendet werden. 2 Diabetes-Management, Sie unterscheiden sich jedoch in ihren Wirkmechanismen und ihrer Wirksamkeit. Hier ist ein Vergleich der beiden Medikamente:
Mechanism of Action
Tirzepatide:
- Duales glukoseabhängiges insulinotropes Polypeptid (GIP) und Glucagon-ähnliches Peptid-1 (GLP-1) Rezeptor-Agonist
- Activates both GIP and GLP-1 receptors
Semaglutide:
- Selective GLP-1 receptor agonist
- Activates only GLP-1 receptors
Effectiveness for Weight Loss
Tirzepatide:
- Associated with greater weight loss compared to semaglutide
- In a study of adults with overweight or obesity:
- Patients were 1.76 times more likely to achieve ≥5% weight loss
- 2.54 times more likely to achieve ≥10% weight loss
- 3.24 times more likely to achieve ≥15% weight loss compared to semaglutide
Semaglutide:
- Effective for weight loss, but generally less so than tirzepatide
- Approved for chronic weight management in adults with obesity or overweight with at least one weight-related condition
- Whatsapp/Telegram:+852 4 401 8390
Email:source@anabolicraws.com